Clinical Trial: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282054) titled 'Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes' on Dec. 02.

Brief Summary: This is a 26-week randomized, open-label, multicenter, active-controlled parallel group trial. The purpose of this study is to compare efficacy and safety of THDB0206 injection with insulin lispro injection combined with insulin glargine injection U-100 in Chinese participants with T1DM.

Study Start Date: April 13, 2022

Study Type: INTERVENTIONAL

Condition: Type 1 Diabetes

Intervention: DRUG: THDB0206

Subcutaneous THDB0206 three times daily, with individualized dose adjustment.

DRUG: Insulin L...